Clinical trial
Randomized Trial of Supplementing Glycine and N-acetylcysteine vs. Placebo in COVID-19
NCT04703036 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Supplementing Glycine and N-acetylcysteine vs. Placebo in COVID-19
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- January 11, 2021
- Completion date
- March 31, 2023
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19